Skip to content
Open access

Prognostic Significance of B7-H3, TROP2, and p16 Expression in Pleural Mesothelioma: Clinicopathological Correlations and Survival Outcomes

Oct 2026 · Journal of Clinical Medicine · Vol 15, pp. 7998 · 0 citations · 25 references
Medicine

TL;DR

B7-H3 is frequently expressed in PM and was associated with poorer survival, including after adjustment for disease stage, which supports further investigation of B7-H3 as a potential prognostic biomarker and therapeutic target in PM.

Abstract

Background: Pleural mesothelioma (PM) is an aggressive malignancy with considerable biological heterogeneity and few established prognostic biomarkers. We evaluated the clinicopathological and prognostic relevance of B7-H3, TROP2, and p16 expression in PM. Methods: This retrospective study included 50 patients with histologically confirmed PM diagnosed between 2016 and 2025. Immunohistochemical expression of B7-H3, TROP2, and p16 was evaluated using an immunoreactivity scoring system. Associations with clinicopathological features were examined, and overall survival (OS) and progression-free survival (PFS) were analyzed using Kaplan–Meier and Cox proportional hazards methods. Results: High B7-H3, TROP2, and p16 expression was observed in 78%, 18%, and 20% of tumors, respectively. High B7-H3 expression was significantly associated with asbestos exposure, chemotherapy, and tumor stage. Patients with high B7-H3 expression had shorter median OS (11.0 vs. 42.0 months; p < 0.001) and PFS (11.0 vs. 40.0 months; p = 0.004) than those with negative/low expression. Neither TROP2 nor p16 expression was significantly associated with survival. In a parsimonious multivariable Cox model, high B7-H3 expression remained significantly associated with poorer OS after adjustment for disease stage (HR = 4.42, 95% CI: 1.29–15.21, p = 0.018). Conclusions: B7-H3 is frequently expressed in PM and was associated with poorer survival, including after adjustment for disease stage. These findings support further investigation of B7-H3 as a potential prognostic biomarker and therapeutic target in PM.

Read PDF

Similar papers

Open access Sep 2026

Association of p16 Loss and EZH2 Overexpression with Clinicopathological Characteristics and Prognosis in Gastrointestinal Stromal Tumors

AbstractAim: Gastrointestinal stromal tumors (GISTs) exhibit marked heterogeneous clinical behavior that is not fully captured by conventional risk classification systems. This study aimed to evaluate the prognostic significance of loss of p16 expression and EZH2 overexpression and their relationship with clinicopathol...

T. Toyran, K. Ateş, T. Köşeci et al. · 0 citations
Oct 2026

Stromal B7-H3 Expression Characterizes an Immune-Hot Microenvironment and Predicts Response to PD-1 Blockade in Gastric Cancer.

PURPOSE We evaluated whether B7-H3, particularly stromal B7-H3, is associated with clinical benefit from programmed cell death protein 1 (PD-1) blockade in gastric cancer (GC) and characterized the immune context underlying this association. MATERIALS AND METHODS B7-H3 expression was evaluated by conventional and mul...

Rui-Peng Wang, Yun-Wen Tao, Han-Qin Xuan et al. · 0 citations
Open access Oct 2026

Association of VCP/p97 Expression with Clinicopathological Features and Overall Survival in Endometrioid Endometrial Carcinoma

Background and Aim: Endometrial cancer is considered one of the most common cancers of the female genital system, with endometrioid endometrial carcinoma (EEC) being the most common subtype. Valosin-containing protein (VCP), or p97, acts as an important regulator of cellular protein homeostasis and is thought to play a...

Akgul Arici, Elif Akçay, Kübra Arslan et al. · 0 citations
Open access Sep 2026

Distinct Associations of PTEN and TMPRSS4 Expression with Clinical Outcomes and Fudan Immunohistochemistry-Based Subtypes in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a heterogeneous and aggressive subtype with limited therapeutic targets. We retrospectively evaluated the expression of phosphatase and tensin homolog (PTEN) and transmembrane serine protease 4 (TMPRSS4) by immunohistochemistry in formalin-fixed, paraffin-embedded tumor tissues f...

W. Hou, Sheng Zhang, Xi Wei et al. · 0 citations
Open access Sep 2026

TROP2 expression in gastric and GEJ adenocarcinomas: associations with clinicopathological features, biomarkers, and treatment outcomes

Background Trophoblast cell surface antigen 2 (TROP2) is frequently expressed in solid tumors, including gastric cancer (GC) and gastroesophageal junction cancer (GEJC), but its distribution and clinical relevance remain unclear. Patients and methods We analyzed patients with GC/GEJC who underwent prospective multibiom...

Y. Tong, I. Nakayama, N. Sakamoto et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.